ES2582369T3 - Método optimizado y definido para el aislamiento y la preservación de células precursoras de cordón umbilical humano - Google Patents
Método optimizado y definido para el aislamiento y la preservación de células precursoras de cordón umbilical humanoInfo
- Publication number
- ES2582369T3 ES2582369T3 ES08807881.1T ES08807881T ES2582369T3 ES 2582369 T3 ES2582369 T3 ES 2582369T3 ES 08807881 T ES08807881 T ES 08807881T ES 2582369 T3 ES2582369 T3 ES 2582369T3
- Authority
- ES
- Spain
- Prior art keywords
- digestion
- flask
- cell
- stage
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003954 umbilical cord Anatomy 0.000 title abstract description 9
- 239000002243 precursor Substances 0.000 title description 5
- 238000000034 method Methods 0.000 title description 3
- 238000002955 isolation Methods 0.000 title 1
- 238000004321 preservation Methods 0.000 title 1
- 230000029087 digestion Effects 0.000 abstract description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract description 16
- 239000000243 solution Substances 0.000 abstract description 13
- 210000001519 tissue Anatomy 0.000 abstract description 13
- 239000001963 growth medium Substances 0.000 abstract description 12
- 210000002966 serum Anatomy 0.000 abstract description 8
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract description 8
- 241000283690 Bos taurus Species 0.000 abstract description 7
- 239000003242 anti bacterial agent Substances 0.000 abstract description 7
- 229940088710 antibiotic agent Drugs 0.000 abstract description 7
- 230000001605 fetal effect Effects 0.000 abstract description 7
- 239000006228 supernatant Substances 0.000 abstract description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- 239000006285 cell suspension Substances 0.000 abstract description 6
- 238000005138 cryopreservation Methods 0.000 abstract description 6
- 238000011084 recovery Methods 0.000 abstract description 6
- 208000007536 Thrombosis Diseases 0.000 abstract description 5
- 229930182555 Penicillin Natural products 0.000 abstract description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract description 4
- 238000005119 centrifugation Methods 0.000 abstract description 4
- 238000005194 fractionation Methods 0.000 abstract description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract description 4
- 238000011534 incubation Methods 0.000 abstract description 4
- 229940049954 penicillin Drugs 0.000 abstract description 4
- 239000002342 ribonucleoside Substances 0.000 abstract description 4
- 229960005322 streptomycin Drugs 0.000 abstract description 4
- 210000001691 amnion Anatomy 0.000 abstract description 3
- 230000010261 cell growth Effects 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- 230000003068 static effect Effects 0.000 abstract description 3
- 239000012808 vapor phase Substances 0.000 abstract description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 abstract description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 abstract description 2
- 229940119679 deoxyribonucleases Drugs 0.000 abstract description 2
- 239000005549 deoxyribonucleoside Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 abstract 3
- 235000019797 dipotassium phosphate Nutrition 0.000 abstract 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 abstract 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 abstract 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 3
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 3
- 235000019799 monosodium phosphate Nutrition 0.000 abstract 3
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 3
- 239000011780 sodium chloride Substances 0.000 abstract 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract 3
- 229910000162 sodium phosphate Inorganic materials 0.000 abstract 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 2
- 102000029816 Collagenase Human genes 0.000 abstract 2
- 108060005980 Collagenase Proteins 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 102000004142 Trypsin Human genes 0.000 abstract 2
- 108090000631 Trypsin Proteins 0.000 abstract 2
- 239000001110 calcium chloride Substances 0.000 abstract 2
- 235000011148 calcium chloride Nutrition 0.000 abstract 2
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 2
- 229960002424 collagenase Drugs 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 239000012588 trypsin Substances 0.000 abstract 2
- 108020004705 Codon Proteins 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 238000013019 agitation Methods 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 244000309466 calf Species 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 238000006911 enzymatic reaction Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000010355 oscillation Effects 0.000 abstract 1
- 238000010187 selection method Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 37
- 239000002609 medium Substances 0.000 description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 239000012091 fetal bovine serum Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000009815 adipogenic differentiation Effects 0.000 description 4
- 230000009816 chondrogenic differentiation Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229930040373 Paraformaldehyde Natural products 0.000 description 3
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000009818 osteogenic differentiation Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- MZIYRTZAYQIAHW-UHFFFAOYSA-N 1-methyl-8-(2-methylpropyl)-3,7-dihydropurine-2,6-dione Chemical compound N1C(=O)N(C)C(=O)C2=C1N=C(CC(C)C)N2 MZIYRTZAYQIAHW-UHFFFAOYSA-N 0.000 description 1
- JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pregnancy & Childbirth (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT103843A PT103843B (pt) | 2007-10-04 | 2007-10-04 | Método de isolamento de células precursoras a partir do cordão umbilical humano |
| PT10384307 | 2007-10-04 | ||
| PCT/IB2008/054067 WO2009044379A2 (en) | 2007-10-04 | 2008-10-03 | Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2582369T3 true ES2582369T3 (es) | 2016-09-12 |
Family
ID=40456372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08807881.1T Active ES2582369T3 (es) | 2007-10-04 | 2008-10-03 | Método optimizado y definido para el aislamiento y la preservación de células precursoras de cordón umbilical humano |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9546353B2 (https=) |
| EP (1) | EP2203555B1 (https=) |
| JP (1) | JP5785394B2 (https=) |
| KR (1) | KR20100087705A (https=) |
| CN (1) | CN101868536B (https=) |
| AU (1) | AU2008306442B2 (https=) |
| BR (1) | BRPI0817522A2 (https=) |
| CA (1) | CA2701907A1 (https=) |
| EA (1) | EA025532B1 (https=) |
| ES (1) | ES2582369T3 (https=) |
| IL (1) | IL204788A (https=) |
| MX (1) | MX2010003511A (https=) |
| PT (1) | PT103843B (https=) |
| WO (1) | WO2009044379A2 (https=) |
| ZA (1) | ZA201002260B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2576768B1 (en) | 2010-06-01 | 2017-05-10 | Auxocell Laboratories, Inc. | Native wharton's jelly stem cells and their purification |
| TWI523947B (zh) * | 2010-10-18 | 2016-03-01 | 尚翔股份有限公司 | 人類多能性類胚胎幹細胞先驅細胞 |
| TWI535377B (zh) * | 2011-09-01 | 2016-06-01 | Storage, culture and application of umbilical cord tissue and its derived cells | |
| HUE056817T2 (hu) * | 2011-12-30 | 2022-03-28 | Amit Patel | Eljárások és készítmények allogén sejt klinikai származtatására és terápiás alkalmazások |
| CN102550543B (zh) * | 2012-02-10 | 2014-04-16 | 四川新生命干细胞科技股份有限公司 | 用于保存脐带组织的液体 |
| CN103461322B (zh) * | 2012-06-07 | 2016-08-03 | 西比曼生物科技（上海）有限公司 | 用于冻存复苏后的细胞的保存液 |
| EP2756754B1 (de) | 2013-01-17 | 2017-01-04 | Vita 34 Ag | Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes |
| US20170119824A1 (en) * | 2014-05-24 | 2017-05-04 | Neelam Krishnan Venkataramanaa | A method for the treatment of glioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord |
| JP2017533917A (ja) * | 2014-11-05 | 2017-11-16 | ティッシュテック，インク． | 神経成長および再生を促進するための組成物および方法 |
| US10006003B2 (en) * | 2015-06-30 | 2018-06-26 | Surgenex, LLC | Compositions and methods for flowable allograft amniotic tissue |
| WO2017096611A1 (zh) * | 2015-12-11 | 2017-06-15 | 郭镭 | 一种从脐带华通氏胶组织中分离培养脐带间充质干细胞的方法 |
| WO2019175773A1 (en) | 2018-03-12 | 2019-09-19 | Universidade Do Porto | Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells |
| CN112342191A (zh) * | 2019-08-07 | 2021-02-09 | 路春光 | hMSC生产试剂盒开发和质量管理标准优化和体系建立 |
| CN111893092A (zh) * | 2020-06-28 | 2020-11-06 | 国大生命科学产业集团(深圳)有限公司 | 一种人脐带来源的间充质干细胞及其制备方法 |
| CN113025567A (zh) * | 2021-03-31 | 2021-06-25 | 中国人民解放军陆军特色医学中心 | 一种椎间盘单细胞的分离方法 |
| DE102021116694B4 (de) * | 2021-06-29 | 2023-03-09 | Promocell Gmbh | Wässrige Lösung zur Zellkonservierung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT402890B (de) * | 1994-03-16 | 1997-09-25 | Berbi Gmbh | Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln |
| AU2003221173A1 (en) * | 2002-03-27 | 2003-10-08 | Asahi Kasei Kabushiki Kaisha | Placenta-origin mesenchymal cells and medicinal use thereof |
| ZA200804717B (en) * | 2005-12-29 | 2010-02-24 | Anthrogenesis Corp | Improved composition for collecting and preserving a placental stem cells and methods of using the composition |
| CN101611139B (zh) * | 2006-11-13 | 2012-07-04 | 伊西康公司 | 利用微载体的产后来源的细胞的体外扩增 |
-
2007
- 2007-10-04 PT PT103843A patent/PT103843B/pt active IP Right Grant
-
2008
- 2008-10-03 AU AU2008306442A patent/AU2008306442B2/en not_active Ceased
- 2008-10-03 JP JP2010527592A patent/JP5785394B2/ja not_active Expired - Fee Related
- 2008-10-03 MX MX2010003511A patent/MX2010003511A/es active IP Right Grant
- 2008-10-03 KR KR1020107009850A patent/KR20100087705A/ko not_active Ceased
- 2008-10-03 ES ES08807881.1T patent/ES2582369T3/es active Active
- 2008-10-03 EA EA201000425A patent/EA025532B1/ru not_active IP Right Cessation
- 2008-10-03 CN CN200880114557.0A patent/CN101868536B/zh not_active Expired - Fee Related
- 2008-10-03 WO PCT/IB2008/054067 patent/WO2009044379A2/en not_active Ceased
- 2008-10-03 EP EP08807881.1A patent/EP2203555B1/en not_active Not-in-force
- 2008-10-03 BR BRPI0817522-5A2A patent/BRPI0817522A2/pt not_active Application Discontinuation
- 2008-10-03 CA CA2701907A patent/CA2701907A1/en not_active Abandoned
- 2008-10-03 US US12/680,604 patent/US9546353B2/en not_active Expired - Fee Related
-
2010
- 2010-03-28 IL IL204788A patent/IL204788A/en not_active IP Right Cessation
- 2010-03-30 ZA ZA2010/02260A patent/ZA201002260B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9546353B2 (en) | 2017-01-17 |
| KR20100087705A (ko) | 2010-08-05 |
| MX2010003511A (es) | 2010-09-10 |
| IL204788A (en) | 2013-07-31 |
| EA025532B1 (ru) | 2017-01-30 |
| US20100216237A1 (en) | 2010-08-26 |
| BRPI0817522A2 (pt) | 2014-10-14 |
| JP2010539970A (ja) | 2010-12-24 |
| ZA201002260B (en) | 2011-06-29 |
| CA2701907A1 (en) | 2009-04-09 |
| WO2009044379A2 (en) | 2009-04-09 |
| AU2008306442B2 (en) | 2014-12-04 |
| PT103843B (pt) | 2008-08-12 |
| EA201000425A1 (ru) | 2010-10-29 |
| PT103843A (pt) | 2008-01-09 |
| WO2009044379A3 (en) | 2009-05-22 |
| EP2203555A2 (en) | 2010-07-07 |
| CN101868536B (zh) | 2015-03-25 |
| IL204788A0 (en) | 2010-12-30 |
| EP2203555B1 (en) | 2016-04-13 |
| AU2008306442A1 (en) | 2009-04-09 |
| CN101868536A (zh) | 2010-10-20 |
| JP5785394B2 (ja) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2582369T3 (es) | Método optimizado y definido para el aislamiento y la preservación de células precursoras de cordón umbilical humano | |
| JP7262775B2 (ja) | 細胞培養液を用いて臍帯羊膜から間葉系幹細胞を単離する方法 | |
| CN104480533A (zh) | 一种胎盘干细胞库的构建方法及胎盘组织复苏方法 | |
| DK2576768T3 (en) | NATIVE WHARTONS JELLY STEM CELLS AND CLEANING THEREOF | |
| CN107022521A (zh) | 壁蜕膜组织冻存、复苏及分离培养间充质干细胞的方法 | |
| CN105961374A (zh) | 细胞冻存液 | |
| CN103469309B (zh) | 一种组织匀浆法分离活细胞构建细胞库的方法 | |
| EP2271208A1 (en) | Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue | |
| JP7541730B2 (ja) | 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法 | |
| CN106047702A (zh) | 一种用于培养脂肪干细胞的试剂盒及培养方法 | |
| KR20180006462A (ko) | 미립자 동결건조된 혈소판 용해물 조성물 | |
| KR20120117209A (ko) | 줄기세포 동결보존액 및 이를 이용하는 줄기세포 동결보존방법 | |
| CN107354130B (zh) | 一种人胎盘绒毛膜间充质干细胞分离方法 | |
| CN106417253A (zh) | 一种骨骼肌干细胞的冻存液和冻存方法 | |
| Gartner | The macrophage and HIV: basic concepts and methodologies | |
| CN107805626A (zh) | 一种人脐带间充质干细胞的复苏方法 | |
| CN109750065B (zh) | 一种小鼠肠上皮隐窝细胞系及其构建与培养方法 | |
| CN112852723A (zh) | 一种原代胎盘壁蜕膜间充质干细胞的处理和培养方法 | |
| JP2024112404A (ja) | 間葉系幹細胞の培養方法 | |
| CN115968862A (zh) | 一种细胞冻存液及其应用 | |
| CN116926003B (zh) | 一种羊膜间充质干细胞的制备方法及其应用 | |
| Taherian et al. | Cryopreservation of Stem Cells in Tissue Engineering and Regenerative Medicine | |
| CN115777691A (zh) | 一种胎盘组织冻存、复苏和制备间充质干细胞的方法 | |
| Miszta-Lane et al. | Effect of slow freezing versus vitrification on the recovery of mouse embryonic stem cells | |
| RU2505602C1 (ru) | Способ получения резидентных стволовых клеток сердца млекопитающего из образцов миокарда |